| 查看: 68 | 回复: 0 | ||
| 当前主题已经存档。 | ||
[资源]
Medicinal Mushrooms
|
||
|
Medicinal mushrooms: their therapeutic properties and current medical usage with special emphasis on cancer treatments. Authors: JOHN E SMITH BSc MSc PhD DSc FIBiol FRSE Emeritus Professor of Applied Microbiology, University of Strathclyde Chief Scientific Officer, MycoBiotech Ltd, Singapore NEIL J ROWAN BSc MSc PhD MIBiol MIFST Lecturer, Department of Bioscience, University of Strathclyde RICHARD SULLIVAN BSc MD PhD Head of Clinical Programmes, Cancer Research UK Introduction Many of the currently available anti-cancer agents are derived form natural products, for instance paclitaxel (Taxol), and camptothecin (Hycamtin) amongst many others. In 2000 Professor Gordon McVie, Director-General of the Cancer Research Campaign (now Cancer Research UK) and Professor John Smith of University of Strathclyde met in Glasgow to discuss the role of medicinal mushrooms in the treatment of cancer. The CRC had become aware that these natural products were being used extensively in the Far East as nutriceuticals (dietary supplements) and as a source for the generation of pharmaceutical-grade medicines to treat a wide variety of diseases, including cancer. The substantial range of medicinal mushroom species from which different bioactive compounds can be derived suggested that the humble mushroom could be a source of novel anti-cancer agents. This monograph is a comprehensive overview of this subject from the technology of cultivation, extraction and chemistry of medicinal mushroom bioactive compounds to the clinical evidence that suggests an important therapeutic role in cancer, and other major diseases. FREE download also available here (on a chapter by chapter basis): http://www.glyconutrients-center ... edicinal-cancer.php |
» 猜你喜欢
为什么网上很多人说本周 12号出结果
已经有4人回复
基金中了
已经有15人回复
帮忙看看fileCode
已经有8人回复
小木虫上这么多卖论文的,真有人买论文么?感觉没必要啊
已经有3人回复
FileCode能看出啥?
已经有15人回复
filecode
已经有8人回复
确定了,国自然21号放榜
已经有7人回复
综述论文作为代表作会不会影响评审专家的印象分?
已经有11人回复
关于代码变化问题,想知道的进来
已经有24人回复
静等基金结果
已经有16人回复










回复此楼